Japan Immunotherapy Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Immunotherapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Johnson & Johnson

    • Merck

    • Celgene

    • Abbvie

    • Pfizer

    • Novartis.

    • Amgen, Inc

    • Biogen

    • Bristol-Myers Squibb

    • Roche

    By Type:

    • Monoclonal Antibodies

    • Therapeutic Vaccines

    • Checkpoint Inhibitors

    • Non-Specific Immunotherapy

    By End-User:

    • Oncology

    • Inflammation

    • Central Nervous System

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Immunotherapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

      • 1.3.2 Japan Immunotherapy Market Size and Growth Rate of Therapeutic Vaccines from 2014 to 2026

      • 1.3.3 Japan Immunotherapy Market Size and Growth Rate of Checkpoint Inhibitors from 2014 to 2026

      • 1.3.4 Japan Immunotherapy Market Size and Growth Rate of Non-Specific Immunotherapy from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Immunotherapy Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Japan Immunotherapy Market Size and Growth Rate of Inflammation from 2014 to 2026

      • 1.4.3 Japan Immunotherapy Market Size and Growth Rate of Central Nervous System from 2014 to 2026

      • 1.4.4 Japan Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Immunotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Immunotherapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal Antibodies

      • 3.4.2 Market Size and Growth Rate of Therapeutic Vaccines

      • 3.4.3 Market Size and Growth Rate of Checkpoint Inhibitors

      • 3.4.4 Market Size and Growth Rate of Non-Specific Immunotherapy

    4 Segmentation of Immunotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Immunotherapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Immunotherapy in Oncology

      • 4.4.2 Market Size and Growth Rate of Immunotherapy in Inflammation

      • 4.4.3 Market Size and Growth Rate of Immunotherapy in Central Nervous System

      • 4.4.4 Market Size and Growth Rate of Immunotherapy in Others

    5 Market Analysis by Regions

    • 5.1 Japan Immunotherapy Production Analysis by Regions

    • 5.2 Japan Immunotherapy Consumption Analysis by Regions

    6 Hokkaido Immunotherapy Landscape Analysis

    • 6.1 Hokkaido Immunotherapy Landscape Analysis by Major Types

    • 6.2 Hokkaido Immunotherapy Landscape Analysis by Major End-Users

    7 Tohoku Immunotherapy Landscape Analysis

    • 7.1 Tohoku Immunotherapy Landscape Analysis by Major Types

    • 7.2 Tohoku Immunotherapy Landscape Analysis by Major End-Users

    8 Kanto Immunotherapy Landscape Analysis

    • 8.1 Kanto Immunotherapy Landscape Analysis by Major Types

    • 8.2 Kanto Immunotherapy Landscape Analysis by Major End-Users

    9 Chubu Immunotherapy Landscape Analysis

    • 9.1 Chubu Immunotherapy Landscape Analysis by Major Types

    • 9.2 Chubu Immunotherapy Landscape Analysis by Major End-Users

    10 Kinki Immunotherapy Landscape Analysis

    • 10.1 Kinki Immunotherapy Landscape Analysis by Major Types

    • 10.2 Kinki Immunotherapy Landscape Analysis by Major End-Users

    11 Chugoku Immunotherapy Landscape Analysis

    • 11.1 Chugoku Immunotherapy Landscape Analysis by Major Types

    • 11.2 Chugoku Immunotherapy Landscape Analysis by Major End-Users

    12 Shikoku Immunotherapy Landscape Analysis

    • 12.1 Shikoku Immunotherapy Landscape Analysis by Major Types

    • 12.2 Shikoku Immunotherapy Landscape Analysis by Major End-Users

    13 Kyushu Immunotherapy Landscape Analysis

    • 13.1 Kyushu Immunotherapy Landscape Analysis by Major Types

    • 13.2 Kyushu Immunotherapy Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Johnson & Johnson

      • 14.1.1 Johnson & Johnson Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Merck

      • 14.2.1 Merck Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Celgene

      • 14.3.1 Celgene Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Abbvie

      • 14.4.1 Abbvie Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Novartis.

      • 14.6.1 Novartis. Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Amgen, Inc

      • 14.7.1 Amgen, Inc Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Biogen

      • 14.8.1 Biogen Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Bristol-Myers Squibb

      • 14.9.1 Bristol-Myers Squibb Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Roche

      • 14.10.1 Roche Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 103 Figures and 132 Tables)

    • Figure Japan Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Therapeutic Vaccines from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Checkpoint Inhibitors from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Non-Specific Immunotherapy from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Inflammation from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Central Nervous System from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Immunotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Immunotherapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Immunotherapy by Different Types from 2014 to 2026

    • Table Consumption Share of Immunotherapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Therapeutic Vaccines

    • Figure Market Size and Growth Rate of Checkpoint Inhibitors

    • Figure Market Size and Growth Rate of Non-Specific Immunotherapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Immunotherapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Immunotherapy by Different End-Users from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Inflammation from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Central Nervous System from 2014 to 2026

    • Figure Japan Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Immunotherapy Production by Regions

    • Table Japan Immunotherapy Production Share by Regions

    • Figure Japan Immunotherapy Production Share by Regions in 2014

    • Figure Japan Immunotherapy Production Share by Regions in 2018

    • Figure Japan Immunotherapy Production Share by Regions in 2026

    • Table Japan Immunotherapy Consumption by Regions

    • Table Japan Immunotherapy Consumption Share by Regions

    • Figure Japan Immunotherapy Consumption Share by Regions in 2014

    • Figure Japan Immunotherapy Consumption Share by Regions in 2018

    • Figure Japan Immunotherapy Consumption Share by Regions in 2026

    • Table Hokkaido Immunotherapy Consumption by Types from 2014 to 2026

    • Table Hokkaido Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Immunotherapy Consumption Share by Types in 2014

    • Figure Hokkaido Immunotherapy Consumption Share by Types in 2018

    • Figure Hokkaido Immunotherapy Consumption Share by Types in 2026

    • Table Hokkaido Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Immunotherapy Consumption Share by End-Users in 2014

    • Figure Hokkaido Immunotherapy Consumption Share by End-Users in 2018

    • Figure Hokkaido Immunotherapy Consumption Share by End-Users in 2026

    • Table Tohoku Immunotherapy Consumption by Types from 2014 to 2026

    • Table Tohoku Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Immunotherapy Consumption Share by Types in 2014

    • Figure Tohoku Immunotherapy Consumption Share by Types in 2018

    • Figure Tohoku Immunotherapy Consumption Share by Types in 2026

    • Table Tohoku Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Tohoku Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Immunotherapy Consumption Share by End-Users in 2014

    • Figure Tohoku Immunotherapy Consumption Share by End-Users in 2018

    • Figure Tohoku Immunotherapy Consumption Share by End-Users in 2026

    • Table Kanto Immunotherapy Consumption by Types from 2014 to 2026

    • Table Kanto Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Kanto Immunotherapy Consumption Share by Types in 2014

    • Figure Kanto Immunotherapy Consumption Share by Types in 2018

    • Figure Kanto Immunotherapy Consumption Share by Types in 2026

    • Table Kanto Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Kanto Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Immunotherapy Consumption Share by End-Users in 2014

    • Figure Kanto Immunotherapy Consumption Share by End-Users in 2018

    • Figure Kanto Immunotherapy Consumption Share by End-Users in 2026

    • Table Chubu Immunotherapy Consumption by Types from 2014 to 2026

    • Table Chubu Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Chubu Immunotherapy Consumption Share by Types in 2014

    • Figure Chubu Immunotherapy Consumption Share by Types in 2018

    • Figure Chubu Immunotherapy Consumption Share by Types in 2026

    • Table Chubu Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Chubu Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Immunotherapy Consumption Share by End-Users in 2014

    • Figure Chubu Immunotherapy Consumption Share by End-Users in 2018

    • Figure Chubu Immunotherapy Consumption Share by End-Users in 2026

    • Table Kinki Immunotherapy Consumption by Types from 2014 to 2026

    • Table Kinki Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Kinki Immunotherapy Consumption Share by Types in 2014

    • Figure Kinki Immunotherapy Consumption Share by Types in 2018

    • Figure Kinki Immunotherapy Consumption Share by Types in 2026

    • Table Kinki Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Kinki Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Immunotherapy Consumption Share by End-Users in 2014

    • Figure Kinki Immunotherapy Consumption Share by End-Users in 2018

    • Figure Kinki Immunotherapy Consumption Share by End-Users in 2026

    • Table Chugoku Immunotherapy Consumption by Types from 2014 to 2026

    • Table Chugoku Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Immunotherapy Consumption Share by Types in 2014

    • Figure Chugoku Immunotherapy Consumption Share by Types in 2018

    • Figure Chugoku Immunotherapy Consumption Share by Types in 2026

    • Table Chugoku Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Chugoku Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Immunotherapy Consumption Share by End-Users in 2014

    • Figure Chugoku Immunotherapy Consumption Share by End-Users in 2018

    • Figure Chugoku Immunotherapy Consumption Share by End-Users in 2026

    • Table Shikoku Immunotherapy Consumption by Types from 2014 to 2026

    • Table Shikoku Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Immunotherapy Consumption Share by Types in 2014

    • Figure Shikoku Immunotherapy Consumption Share by Types in 2018

    • Figure Shikoku Immunotherapy Consumption Share by Types in 2026

    • Table Shikoku Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Shikoku Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Immunotherapy Consumption Share by End-Users in 2014

    • Figure Shikoku Immunotherapy Consumption Share by End-Users in 2018

    • Figure Shikoku Immunotherapy Consumption Share by End-Users in 2026

    • Table Kyushu Immunotherapy Consumption by Types from 2014 to 2026

    • Table Kyushu Immunotherapy Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Immunotherapy Consumption Share by Types in 2014

    • Figure Kyushu Immunotherapy Consumption Share by Types in 2018

    • Figure Kyushu Immunotherapy Consumption Share by Types in 2026

    • Table Kyushu Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Kyushu Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Immunotherapy Consumption Share by End-Users in 2014

    • Figure Kyushu Immunotherapy Consumption Share by End-Users in 2018

    • Figure Kyushu Immunotherapy Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Celgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

    • Figure Sales and Growth Rate Analysis of Celgene

    • Figure Revenue and Market Share Analysis of Celgene

    • Table Product and Service Introduction of Celgene

    • Table Company Profile and Development Status of Abbvie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie

    • Figure Sales and Growth Rate Analysis of Abbvie

    • Figure Revenue and Market Share Analysis of Abbvie

    • Table Product and Service Introduction of Abbvie

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Novartis.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis.

    • Figure Sales and Growth Rate Analysis of Novartis.

    • Figure Revenue and Market Share Analysis of Novartis.

    • Table Product and Service Introduction of Novartis.

    • Table Company Profile and Development Status of Amgen, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc

    • Figure Sales and Growth Rate Analysis of Amgen, Inc

    • Figure Revenue and Market Share Analysis of Amgen, Inc

    • Table Product and Service Introduction of Amgen, Inc

    • Table Company Profile and Development Status of Biogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen

    • Figure Sales and Growth Rate Analysis of Biogen

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Product and Service Introduction of Biogen

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.